Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advixa vs Humira in Healthy Subjects and Rheumatoid Arthritis Patients
NCT05172817Phase 3Unknown
- Start
- Jun 2021
- Primary completion
- Nov 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Advixa in rheumatoid arthritis (RA). Primary endpoint: Peak Plasma Concentration at 64 days. Status: unknown.
02
Drugs
Advixa
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05172817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05172817.